Elsevier

Biochimie

Volume 89, Issues 6–7, June–July 2007, Pages 799-811
Biochimie

The dsRNA protein kinase PKR: Virus and cell control

https://doi.org/10.1016/j.biochi.2007.03.001Get rights and content

Abstract

The IFN-induced double-stranded RNA-dependent protein kinase (PKR) is one of the four mammalian serine-threonine kinases (the three others being HRI, GCN2 and PERK) that phosphorylate the eIF2α translation initiation factor, in response to stress signals, mainly as a result of viral infections. eIF2α phosphorylation results in arrest of translation of both cellular and viral mRNAs, an efficient way to inhibit virus replication. The particularity of PKR is to activate by binding to dsRNA through two N terminal dsRNA binding motifs (dsRBM). PKR activation during a viral infection represents a threat for several viruses, which have therefore evolved to express PKR inhibitors, such as the Vaccinia E3L and K3L proteins. The function of PKR can also be regulated by cellular proteins, either positively (RAX/PACT; Mda7) or negatively (p58IPK, TRBP, nucleophosmin, Hsp90/70). PKR can provoke apoptosis, in part through its ability to control protein translation, but the situation appears to be more complex, as NF-κB, ATF-3 and p53 have also been implicated. PKR-induced apoptosis involves mainly the FADD/caspase 8 pathway, while the mitochondrial APAF/caspase 9 pathway is also engaged. As a consequence of the effects of PKR on translation, transcription and apoptosis, PKR can function to control cell growth and cell differentiation, and its activity can be controlled by the action of several oncogenes.

Introduction

Interferons (IFNs) have a wide range of biological functions, including antiviral, antiproliferative and immunomodulatory properties [1], [2]. The cloning of the interferon genes, the structure of the ligand and their receptors, the signalling pathways and transcription of IFN-induced genes has been instrumental in the understanding of how these molecules exert their function in the cell [3], [4]. This knowledge opened the way to the discovery of similar signalling pathways in the cytokine family. Among the molecules with important biological function induced by IFN is the doubled-stranded (ds) RNA-dependent protein kinase (PKR), an enzyme with multiple effects in cells, which plays a critical role in the antiviral defence mechanism of the host [5].

PKR was discovered after it was observed that IFN-treated vaccinia virus (VV) infected cells have a translational block of viral mRNAs and that cell extracts prepared from these IFN-treated VV-infected cells showed restricted translation of viral and cellular mRNAs [6], [7]. At this time, VV was known to produce dsRNA [8] and dsRNA was also known to inhibit protein synthesis in animal cells or in cell free systems [9], [10]. The group of Ian Kerr showed that extracts from IFN-pretreated cells had enhanced sensitivity to inhibition by dsRNA [11]. One reason for this inhibition was the generation of 2′-5′A oligonucleotides after activation by dsRNA of the IFN-induced 2′-5′A-oligoadenylate synthetase, leading to activation of the 2′-5′A/RNAse L pathway (see review by A.G. Hovanessian and J. Justesen in this issue). Another reason for this inhibition was the activation of a protein kinase. Whereas the discovery of 2′-5′A was unexpected, a kinase activity responsible for inhibition was under active search in different laboratories, after the demonstration that a dsRNA-dependent kinase could inhibit translation through phosphorylation of the alpha subunit of eukaryotic initiation factor 2 (eIF2α) in rabbit reticulocyte lysates [12]. Similarly to the 2-5′A-oligoadenylate synthetase, the IFN-induced protein kinase could bind dsRNA. This facilitated the earlier studies on this protein, through partial purification on poly(I):poly(C)-Sepharose [13]. In addition to eIF2α, the kinase activity was found to phosphorylate a p68 protein in human cells and a p65 protein in murine cells [14]. The generation of polyclonal and monoclonal antibodies against the human p68 protein allowed one to determine that this was the kinase itself [15]. To achieve its cloning, which was performed at the Pasteur Institute [16], this kinase had to be first purified by immunoaffinity with specific monoclonal antibodies [17], then the purified protein was injected into mice, in presence of poly(A).poly(U), an adjuvant both very efficient and not toxic [18]. Different names were given to this kinase such as p68 protein kinase, DAI (Double stranded Activated Inhibitor), dsRNA-dependent protein kinase, P1/eIF2α kinase until the decision to give PKR as consensus name, for Protein Kinase dsRNA-dependent [19].

PKR is a serine-threonine kinase, composed by the kinase domain shared by the other eIF2α kinases, and two dsRNA binding domains (dsRBD) that regulate its activity. PKR autophosphorylation represents the activation reaction and leads to the phosphorylation of eIF-2α [20], [21], impairing eIF-2 activity that results in inhibition of protein synthesis [22]. In addition to its translational regulatory function, PKR has a role in signal transduction and transcriptional control through the IκB/NF-κB pathway [23]. PKR, which is expressed constitutively in mammalian cells, has also been implicated in the control of cell growth and proliferation with tumour suppressor function [24], [25], [26].

PKR is involved in signalling various pathways that activate and engage a number of transcription factors (Fig. 1). Since these transcription factors regulate the expression of many cellular genes, it is anticipated that PKR control the expression of multiple genes.

Section snippets

PKR activation

PKR is activated in response to dsRNA of cellular, viral, or synthetic (such as polyrI:polyrC, pIC) origin, with a size greater than 30 nucleotides. PKR mediates a critical role in response to dsRNA, acting as a sensor of viral infections. Moreover, PKR is stimulated by a set of other activators such as pro-inflammatory stimuli, growth factors, cytokines and oxidative stress. A wide range of different cell stresses can activate PKR independently of dsRNA or other molecules through PACT

Translation regulation by PKR

PKR is one of the four mammalian kinases (the others are GCN2, PERK and HRI) that phosphorylate eIF2α in response to stress signals, mainly as a result of viral infections [41]. Phosphorylation of eIF2α at residue S51 prevents the recycling of this factor that is required for ongoing translation, leading to general inhibition of translation. As a consequence of dsRNA accumulation in infected cells, PKR-triggered eIF2α phosphorylation also inhibits translation of viral mRNA [42], [43], [44], [45]

Signal transduction and NF-κB activation by PKR

PKR was initially identified because of its ability to regulate translation in response to dsRNA. However, several signal transduction pathways are affected by PKR.

The growth inhibitory function activities of IRF-1 are mediated by PKR [57], and activation of IRF-1 in response to IFN-γ or pIC treatment, is defective in PKR−/− mice [58]. PKR also controls IFN and dsRNA signalling pathways by modulation of STAT1 and STAT3 transcription factors. PKR−/− cells are defective in STAT1 phosphorylation

Regulation of PKR action by cell and viral factors

The biological importance of PKR function is further remarked by the existence of a multitude of cellular and viral regulators of PKR action.

Apoptosis induction by PKR

Several proteins are implicated in triggering cell death in response to dsRNA and viral infections, among them the 2-5′A system and PKR [154].

The first evidence that PKR was involved in apoptosis was obtained in HeLa cells using a VV recombinant vector that expressed the enzyme under inducible conditions [155]. The role of PKR in apoptosis was reinforced by studies carried out in 3T3 cells expressing a non-catalytic mutant PKR or using MEF derived from PKR−/− mice [156], [157].

Since then, it

PKR regulation of cell growth

The multiple effects of PKR in translation, transcription and apoptosis, described in the preceding section, have an impact on cell growth. The first evidence that PKR controls cell growth, and consequently may function as an inhibitor of cell proliferation, was obtained after expression of PKR, which suppresses growth in mammalian, insect, and yeast cells [26], [172]. Conversely, expression of several PKR mutants leads to malignant transformation of NIH-3T3 cells and causes tumourigenesis in

Concluding remarks

PKR has fulfilled the broad spectrum of IFN-mediated biological effects. Through its N terminus, PKR belongs to the large family of dsRNA-binding proteins and thus interacts, not only with a number of viral genomes or transcripts but also with a number of cellular RNAs, thus leading to different levels of regulation. Through its C terminus bearing its catalytic kinase domain, PKR has the power to control protein translation by phosphorylating eIF2α. Through mechanisms yet to be clarified, PKR

Acknowledgements

We are thankful to members of the Esteban group who worked on the PKR project for their contribution. M. Esteban is funded by BIO2005-06264 and is indebted to Fundación Botín for financial support. E.F. Meurs is funded by the Pasteur Institute and by grants from the Agence Nationale pour la Recherche contre le SIDA (ANRS).

References (207)

  • M.J. Clemens

    PKR—a protein kinase regulated by double-stranded RNA

    Int J. Biochem Cell Biol.

    (1997)
  • M. Dey et al.

    Mechanistic link between PKR dimerization, autophosphorylation, and eIF2alpha substrate recognition

    Cell

    (2005)
  • F. Zhang et al.

    Binding of double-stranded RNA to protein kinase PKR is required for dimerization and promotes critical autophosphorylation events in the activation loop

    J. Biol. Chem.

    (2001)
  • A.C. Dar et al.

    Higher-order substrate recognition of eIF2alpha by the RNA-dependent protein kinase PKR

    Cell

    (2005)
  • S. Guerra et al.

    Human gene profiling in response to the active protein kinase, interferon-induced serine/threonine protein kinase (PKR), in infected cells. Involvement of the transcription factor ATF-3 IN PKR-induced apoptosis

    J. Biol. Chem.

    (2006)
  • S.B. Lee et al.

    The interferon-induced double-stranded RNA-activated human p68 protein kinase potently inhibits protein synthesis in cultured cells

    Virology

    (1993)
  • S. Balachandran et al.

    Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection

    Immunity

    (2000)
  • S. Zhu et al.

    Ribosome targeting of PKR is mediated by two double-stranded RNA-binding domains and facilitates in vivo phosphorylation of eukaryotic initiation factor-2

    J. Biol. Chem.

    (1997)
  • Y. Ben-Asouli et al.

    Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR

    Cell

    (2002)
  • I.W. Jeffrey et al.

    Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells

    Exp. Cell Res.

    (1995)
  • W.M. Chu et al.

    JNK2 and IKKbeta are required for activating the innate response to viral infection

    Immunity

    (1999)
  • M. Roff et al.

    Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo

    J. Biol. Chem.

    (1996)
  • S. Ghosh et al.

    Missing pieces in the NF-kappaB puzzle

    Cell

    (2002)
  • S. Yamaoka et al.

    Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation

    Cell

    (1998)
  • M.C. Bonnet et al.

    The N-terminus of PKR is responsible for the activation of the NF-kappaB signaling pathway by interacting with the IKK complex

    Cell Signal

    (2006)
  • A. Daher et al.

    Two dimerization domains in the trans-activation response RNA-binding protein (TRBP) individually reverse the protein kinase R inhibition of HIV-1 long terminal repeat expression

    J. Biol. Chem.

    (2001)
  • I. Edery et al.

    Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: a novel translational control mechanism

    Cell

    (1989)
  • I. Kim et al.

    Specific recognition of HIV TAR RNA by the dsRNA binding domains (dsRBD1-dsRBD2) of PKR

    J. Mol. Biol.

    (2006)
  • B. Datta et al.

    Eukaryotic initiation factor 2-associated glycoprotein, p67, shows differential effects on the activity of certain kinases during serum-starved conditions

    Arch. Biochem. Biophys.

    (2004)
  • Q. Pang et al.

    The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling pathway requires the Fanconi anemia protein

    FANCC.J. Biol. Chem.

    (2002)
  • K. Itahana et al.

    Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation

    Mol. Cell

    (2003)
  • Q. Pang et al.

    Nucleophosmin interacts with and inhibits the catalytic function of eukaryotic initiation factor 2 kinase PKR

    J. Biol. Chem.

    (2003)
  • G.R. Stark et al.

    How cells respond to interferons

    Annu. Rev. Biochem.

    (1998)
  • S. Pestka et al.

    Interferons, interferon-like cytokines, and their receptors

    Immunol. Rev.

    (2004)
  • M.A. Garcia et al.

    Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action

    Microbiol. Mol. Biol. Rev.

    (2006)
  • D.H. Metz et al.

    Interferon inhibits viral protein synthesis in L cells infected with vaccinia virus

    Nature

    (1972)
  • R.M. Friedman et al.

    Mechanism of interferon action: inhibition of viral messenger ribonucleic acid translation in L-cell extracts

    J. Virol.

    (1972)
  • C. Colby et al.

    Double-stranded RNA in vaccinia virus infected cells

    Nature

    (1969)
  • E. Ehrenfeld et al.

    Double-stranded poliovirus RNA inhibits initiation of protein synthesis by reticulocyte lysates

    Proc. Natl. Acad. Sci. U.S.A.

    (1971)
  • B. Cordell-Stewart et al.

    Effect of viral double-stranded RNA on mammalian cells in culture: cytotoxicity under conditions preventing viral replication and protein synthesis

    J. Virol.

    (1973)
  • I.M. Kerr et al.

    Increased sensitivity of cell-free protein synthesis to double-stranded RNA after interferon treatment

    Nature

    (1974)
  • A.G. Hovanessian et al.

    The (2′-5′) oligoadenylate (pppA2′-5′A2′-5′A) synthetase and protein kinase(s) from interferon-treated cells

    Eur. J. Biochem.

    (1979)
  • A.G. Laurent et al.

    Monoclonal antibodies to an interferon-induced Mr 68,000 protein and their use for the detection of double-stranded RNA-dependent protein kinase in human cells

    Proc. Natl. Acad. Sci. U.S.A.

    (1985)
  • J. Galabru et al.

    The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase

    Eur. J. Biochem.

    (1989)
  • M.J. Clemens et al.

    PKR: proposed nomenclature for the RNA-dependent protein kinase induced by interferon

    J. Interferon Res.

    (1993)
  • A.G. Hovanessian

    The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK

    J. Interferon Res.

    (1989)
  • A. Kumar et al.

    Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B

    Proc. Natl. Acad. Sci. U.S.A.

    (1994)
  • A.E. Koromilas et al.

    Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase

    Science

    (1992)
  • P. Lengyel

    Tumor-suppressor genes: news about the interferon connection

    Proc. Natl. Acad. Sci. U.S.A.

    (1993)
  • E.F. Meurs et al.

    Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase

    Proc. Natl. Acad. Sci. U.S.A.

    (1993)
  • Cited by (498)

    • Cryo-EM structure of Influenza A virus NS1 and antiviral protein kinase PKR complex

      2024, Biochemical and Biophysical Research Communications
    View all citing articles on Scopus

    This review represents a condensed and modified version of: M.A. Garcia et al., Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action, Microbiol. Mol. Biol. Rev. 70(4) (2006) 1032–1060.

    View full text